Cargando…

Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq

Autoinflammatory diseases occupy one of a group of primary immunodeficiency diseases that are generally thought to be caused by mutation of genes responsible for innate immunity, rather than by acquired immunity. Mutations related to autoinflammatory diseases occur in 12 genes. For example, low-leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Manabu, Oda, Hirotsugu, Nakagawa, Kenji, Yasumi, Takahiro, Kawai, Tomoki, Izawa, Kazushi, Nishikomori, Ryuta, Heike, Toshio, Ohara, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614572/
https://www.ncbi.nlm.nih.gov/pubmed/28956000
http://dx.doi.org/10.1016/j.bbrep.2016.12.002
_version_ 1783266420874805248
author Nakayama, Manabu
Oda, Hirotsugu
Nakagawa, Kenji
Yasumi, Takahiro
Kawai, Tomoki
Izawa, Kazushi
Nishikomori, Ryuta
Heike, Toshio
Ohara, Osamu
author_facet Nakayama, Manabu
Oda, Hirotsugu
Nakagawa, Kenji
Yasumi, Takahiro
Kawai, Tomoki
Izawa, Kazushi
Nishikomori, Ryuta
Heike, Toshio
Ohara, Osamu
author_sort Nakayama, Manabu
collection PubMed
description Autoinflammatory diseases occupy one of a group of primary immunodeficiency diseases that are generally thought to be caused by mutation of genes responsible for innate immunity, rather than by acquired immunity. Mutations related to autoinflammatory diseases occur in 12 genes. For example, low-level somatic mosaic NLRP3 mutations underlie chronic infantile neurologic, cutaneous, articular syndrome (CINCA), also known as neonatal-onset multisystem inflammatory disease (NOMID). In current clinical practice, clinical genetic testing plays an important role in providing patients with quick, definite diagnoses. To increase the availability of such testing, low-cost high-throughput gene-analysis systems are required, ones that not only have the sensitivity to detect even low-level somatic mosaic mutations, but also can operate simply in a clinical setting. To this end, we developed a simple method that employs two-step tailed PCR and an NGS system, MiSeq platform, to detect mutations in all coding exons of the 12 genes responsible for autoinflammatory diseases. Using this amplicon sequencing system, we amplified a total of 234 amplicons derived from the 12 genes with multiplex PCR. This was done simultaneously and in one test tube. Each sample was distinguished by an index sequence of second PCR primers following PCR amplification. With our procedure and tips for reducing PCR amplification bias, we were able to analyze 12 genes from 25 clinical samples in one MiSeq run. Moreover, with the certified primers designed by our short program—which detects and avoids common SNPs in gene-specific PCR primers—we used this system for routine genetic testing. Our optimized procedure uses a simple protocol, which can easily be followed by virtually any office medical staff. Because of the small PCR amplification bias, we can analyze simultaneously several clinical DNA samples with low cost and can obtain sufficient read numbers to detect a low level of somatic mosaic mutations.
format Online
Article
Text
id pubmed-5614572
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56145722017-09-27 Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq Nakayama, Manabu Oda, Hirotsugu Nakagawa, Kenji Yasumi, Takahiro Kawai, Tomoki Izawa, Kazushi Nishikomori, Ryuta Heike, Toshio Ohara, Osamu Biochem Biophys Rep Research Article Autoinflammatory diseases occupy one of a group of primary immunodeficiency diseases that are generally thought to be caused by mutation of genes responsible for innate immunity, rather than by acquired immunity. Mutations related to autoinflammatory diseases occur in 12 genes. For example, low-level somatic mosaic NLRP3 mutations underlie chronic infantile neurologic, cutaneous, articular syndrome (CINCA), also known as neonatal-onset multisystem inflammatory disease (NOMID). In current clinical practice, clinical genetic testing plays an important role in providing patients with quick, definite diagnoses. To increase the availability of such testing, low-cost high-throughput gene-analysis systems are required, ones that not only have the sensitivity to detect even low-level somatic mosaic mutations, but also can operate simply in a clinical setting. To this end, we developed a simple method that employs two-step tailed PCR and an NGS system, MiSeq platform, to detect mutations in all coding exons of the 12 genes responsible for autoinflammatory diseases. Using this amplicon sequencing system, we amplified a total of 234 amplicons derived from the 12 genes with multiplex PCR. This was done simultaneously and in one test tube. Each sample was distinguished by an index sequence of second PCR primers following PCR amplification. With our procedure and tips for reducing PCR amplification bias, we were able to analyze 12 genes from 25 clinical samples in one MiSeq run. Moreover, with the certified primers designed by our short program—which detects and avoids common SNPs in gene-specific PCR primers—we used this system for routine genetic testing. Our optimized procedure uses a simple protocol, which can easily be followed by virtually any office medical staff. Because of the small PCR amplification bias, we can analyze simultaneously several clinical DNA samples with low cost and can obtain sufficient read numbers to detect a low level of somatic mosaic mutations. Elsevier 2016-12-23 /pmc/articles/PMC5614572/ /pubmed/28956000 http://dx.doi.org/10.1016/j.bbrep.2016.12.002 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Nakayama, Manabu
Oda, Hirotsugu
Nakagawa, Kenji
Yasumi, Takahiro
Kawai, Tomoki
Izawa, Kazushi
Nishikomori, Ryuta
Heike, Toshio
Ohara, Osamu
Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title_full Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title_fullStr Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title_full_unstemmed Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title_short Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq
title_sort accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform miseq
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614572/
https://www.ncbi.nlm.nih.gov/pubmed/28956000
http://dx.doi.org/10.1016/j.bbrep.2016.12.002
work_keys_str_mv AT nakayamamanabu accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT odahirotsugu accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT nakagawakenji accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT yasumitakahiro accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT kawaitomoki accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT izawakazushi accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT nishikomoriryuta accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT heiketoshio accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq
AT oharaosamu accurateclinicalgenetictestingforautoinflammatorydiseasesusingthenextgenerationsequencingplatformmiseq